Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular Carcinoma
暂无分享,去创建一个
R. Lencioni | R. Finn | Yoon-Koo Kang | W. Yeo | Joong-Won Park | Y. Chao | Jun Suk Kim | J. Raoul | B. Polite | C. Baudelet | I. Walters